Mar 28, 2012 8:05am EDT Abide Therapeutics and SCYNEXIS Collaborate in Finding Novel Anti-Viral and Anti-Parasitic Agents
Feb 16, 2012 9:52am EST Morria Biopharmaceuticals Plc Selects SCYNEXIS to Support CMC Activities for MRX-4, a Novel Anti-Inflammatory Drug for Allergic Rhinitis
Dec 19, 2011 9:00am EST MMV and SCYNEXIS Offer 400 Active Compounds for Neglected Disease Drug Research at No Cost
Jul 12, 2011 8:20am EDT Innovative Vector Control Consortium Announces Discovery Project With SCYNEXIS
Nov 11, 2010 12:00pm EST SCYNEXIS Receives Four Grants Under Federal Therapeutic Discovery Project Program
Sep 14, 2010 8:52am EDT SCYNEXIS Announces Presentations of Data From Anti-Fungal Drug Candidate at the 50th ICAAC Meeting
